Thermo Fisher to work with Pfizer-BioNtech on vaccine production in Italy By Reuters

March 25, 2021 admin Stock News 0

© Reuters

MILAN (Reuters) – Thermo Fisher Scientific (NYSE:) said on Thursday it would work with Pfizer (NYSE:) and BioNtech to produce their COVID-19 vaccine in Italy.

“Thermo Fisher is working as part of Pfizer’s global vaccine manufacturing network, and will provide manufacturing services in Italy for the Pfizer-BioNTech COVID-19 vaccine that will be distributed in several markets,” the company said in an emailed statement.

Thermo Fisher added it would provide sterile filling and finished product preparation services at its facility in Monza, outside Milan, during 2021.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*